Harvard Bioscience (HBIO) Other Non-Current Liabilities (2010 - 2026)
Harvard Bioscience (HBIO) reported Other Non-Current Liabilities of $1.1 million for Q1 2026, down 19.07% year-over-year from $1.4 million in Q1 2025, and down 12.39% on a QoQ basis from $1.3 million in Q4 2025.
Harvard Bioscience (HBIO) has 17 years of Other Non-Current Liabilities data on file, last reported at $1.1 million in Q1 2026.
- Quarterly Other Non-Current Liabilities fell 19.07% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (down 19.07% YoY) and the FY2025 annual result came in at $1.3 million, up 4.22% from the prior year.
- Other Non-Current Liabilities slipped to $1.1 million in Q1 2026 per HBIO's latest filing, from $1.3 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $1.6 million in Q2 2024 and bottomed at $418000.0 in Q2 2022.
- The 5-year median for Other Non-Current Liabilities is $1.3 million (2025), against an average of $1.2 million.
- The widest annual swing landed in 2022, when Other Non-Current Liabilities slumped 83.53%; it then surged 150.24% in 2023.
- Tracing HBIO's Other Non-Current Liabilities over 5 years: stood at $1.0 million in 2022, then surged by 46.72% to $1.5 million in 2023, then declined by 14.97% to $1.3 million in 2024, then gained by 4.22% to $1.3 million in 2025, then fell by 12.39% to $1.1 million in 2026.
- Per Business Quant, the three latest HBIO Other Non-Current Liabilities figures stand at $1.1 million (Q1 2026), $1.3 million (Q4 2025), and $1.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Harvard Bioscience | 25.38 Mn | 18.29 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.15 Mn |
| Dec 31, 2025 | 1.31 Mn |
| Sep 30, 2025 | 1.46 Mn |
| Jun 30, 2025 | 1.43 Mn |
| Mar 31, 2025 | 1.42 Mn |
| Dec 31, 2024 | 1.26 Mn |
| Sep 30, 2024 | 1.50 Mn |
| Jun 30, 2024 | 1.61 Mn |
| Mar 31, 2024 | 1.45 Mn |
| Dec 31, 2023 | 1.48 Mn |
| Sep 30, 2023 | 892,000.00 |
| Jun 30, 2023 | 1.05 Mn |
| Mar 31, 2023 | 1.45 Mn |
| Dec 31, 2022 | 1.01 Mn |
| Sep 30, 2022 | 420,000.00 |
| Jun 30, 2022 | 418,000.00 |
| Mar 31, 2022 | 598,000.00 |
| Dec 31, 2021 | 486,000.00 |
| Sep 30, 2021 | 2.47 Mn |
| Jun 30, 2021 | 2.54 Mn |
| Mar 31, 2021 | 2.85 Mn |
| Dec 31, 2020 | 2.85 Mn |
| Sep 30, 2020 | 932,000.00 |
| Jun 30, 2020 | 870,000.00 |
| Mar 31, 2020 | 862,000.00 |
| Dec 31, 2019 | 749,000.00 |
| Sep 30, 2019 | 1.66 Mn |
| Jun 30, 2019 | 1.61 Mn |
| Mar 31, 2019 | 1.36 Mn |
| Dec 31, 2018 | 3.29 Mn |
| Sep 30, 2018 | 3.45 Mn |
| Jun 30, 2018 | 4.06 Mn |
| Mar 31, 2018 | 6.10 Mn |
| Dec 31, 2017 | 1.47 Mn |
| Sep 30, 2017 | 3.53 Mn |
| Jun 30, 2017 | 3.43 Mn |
| Mar 31, 2017 | 3.23 Mn |
| Dec 31, 2016 | 3.18 Mn |
| Sep 30, 2016 | 2.64 Mn |
| Jun 30, 2016 | 2.73 Mn |
| Mar 31, 2016 | 2.90 Mn |
| Dec 31, 2015 | 2.99 Mn |
| Sep 30, 2015 | 4.59 Mn |
| Jun 30, 2015 | 4.68 Mn |
| Mar 31, 2015 | 4.79 Mn |
| Dec 31, 2014 | 4.57 Mn |
| Sep 30, 2014 | 5.41 Mn |
| Jun 30, 2014 | 5.73 Mn |
| Mar 31, 2014 | 4.98 Mn |
| Dec 31, 2013 | 4.98 Mn |
| Sep 30, 2013 | 6.21 Mn |
| Jun 30, 2013 | 5.84 Mn |
| Mar 31, 2013 | 5.66 Mn |
| Dec 31, 2012 | 6.14 Mn |
| Sep 30, 2012 | 4.85 Mn |
| Jun 30, 2012 | 4.82 Mn |
| Mar 31, 2012 | 5.14 Mn |
| Dec 31, 2011 | 4.91 Mn |
| Sep 30, 2011 | 3.49 Mn |
| Jun 30, 2011 | 3.73 Mn |
| Dec 31, 2010 | 4.29 Mn |